The Doctor Is In: Proton Therapy & New 3-D Ultrasound

Content is sponsored and provided by Beaumont Health

October is Breast Cancer Awareness Month.  The American Cancer Society estimates 255,180 new diagnosed and 41,070 deaths in 2017, with more than 40,290 women dying. The good news is that the number of breast cancer survivors has been steadily increasing since the early 1990s. On Wednesday, two experts from Beaumont Health share some of the latest tools in the fight against breast cancer including Proton Therapy and new 3-D Ultrasound.

Our Experts:
Peyman Kabolizadeh, M.D., Radiation Oncologist, Beaumont Health
Lisa Awan, M.D., Radiologist, Beaumont Health

Proton Therapy

The Beaumont Proton Therapy Center offers comprehensive image-guidance systems for proton beam therapy.

It's a treatment option for patients with tumors close to vital organs.

Beaumont is the first pencil beam scanning (PBS) proton center in Michigan.

The PBS technology is optimized for intensity modulated proton therapy (IMPT), the type of proton therapy that is both fastest to deliver and with the best ability to spare healthy tissue.

With IMPT, doctors scan the tumor using the proton beam spot-by-spot and layer-by-layer.

The adjacent critical normal structure will receive significantly minute radiation dose, which results in less damage to healthy tissue and decreased association with toxicities that can lead to secondary malignancies.


New SoftVue Clinical Study at Beaumont

Beaumont Hospital in Dearborn is taking part in clinical study that will compare the performance of its SoftVue breast ultrasound device with mammography in dense breast tissue.

The study will include asymptomatic women with dense breast tissue across several U.S. centers, including about 2,000 patients at Beaumont Hospital in Dearborn.

For the project, called SoftVue Discover Breast Ultrasound Prospective Case Collection, patients will undergo screening digital mammography as well as SoftVue ultrasound exams.

Information will be collected to determine SoftVue's ability to detect cancers not found on mammography alone.

Data from the study will support the company's submission of a premarket approval application to the U.S. Food and Drug Administration for use of SoftVue in combination with mammography for women with dense breasts.

To join the clinical trial call (313) 593-8090

Beaumont his hosting breast health fairs for Breast Cancer Awareness Month.

The goal is to help area women and their families gain a better understanding of breast health and breast cancer facts.

Wednesday, Oct. 4
11 a.m. - 1 p.m.
Beaumont, Grosse Pointe
468 Cadieux Road
lower level, private dining room

Wednesday, Oct. 18
11 a.m. - 1 p.m.
Beaumont, Troy
44201 Dequindre Road
lower level classrooms 1-4, near Garden Café, main hospital

Wednesday, Oct. 25
11 a.m. - 1 p.m.
Beaumont, Royal Oak
3601 West Thirteen Mile Road
outside Mackinac Dining Room, South Tower

false
false
false
Up Next:


false
false
false

Stories you may be interested in - includes Advertiser Stories

false
false
false